Literature DB >> 29409136

Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.

Grant S Schulert1, Mingce Zhang2, Ammar Husami1, Ndate Fall1, Hermine Brunner1, Kejian Zhang1, Randy Q Cron2, Alexei A Grom1.   

Abstract

OBJECTIVE: Macrophage activation syndrome (MAS) is a life-threatening complication of systemic juvenile idiopathic arthritis (JIA) and has pathologic similarity to hemophagocytic lymphohistiocytosis (HLH). Intronic variants in UNC13D are found in patients with familial HLH type 3 (FHLH3), but the role of noncoding variants in MAS is unknown. The objective of this study was to identify deep intronic UNC13D variants in patients with MAS.
METHODS: A custom enrichment library was constructed to sequence a genomic region of ~1 Mb flanking UNC13D in 24 patients with systemic JIA, recurrent MAS, and negative results of prior genetic (exon/coding) testing. The functional consequences of intronic variants were assessed using quantitative polymerase chain reaction in patient-derived peripheral blood mononuclear cells (PBMCs), electromobility shift assay, in vitro transcriptional enhancer assays, and natural killer (NK) cell degranulation assays.
RESULTS: We evaluated a patient with systemic JIA and recurrent MAS in whom a novel functional intronic variant in UNC13D, c.117+143A>G, was observed. This variant occurred in a proposed regulatory region that drives lymphocyte-specific UNC13D expression and is associated with reduced transcript levels in patient PBMCs. This variant also disrupted NF-κB binding to a functional transcriptional enhancer, leading to reduced enhancer activity in vitro. Partial knockdown of UNC13D expression also led to impaired NK cell degranulation. An additional patient was identified with a previously described UNC13D intronic variant, for a total noncoding variant hit rate of 8.3% (2 of 24).
CONCLUSION: These findings highlight the notion that intronic variants in key regulatory regions may be associated with MAS in patients with systemic JIA and support deep sequencing approaches when causative coding variants are not identified.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29409136      PMCID: PMC5984660          DOI: 10.1002/art.40438

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  17 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Novel deep intronic and missense UNC13D mutations in familial haemophagocytic lymphohistiocytosis type 3.

Authors:  Miriam Entesarian; Samuel C C Chiang; Heinrich Schlums; Marie Meeths; Mei-Yoke Chan; Soe-Nwe Mya; Shui-Yen Soh; Magnus Nordenskjöld; Jan-Inge Henter; Yenan T Bryceson
Journal:  Br J Haematol       Date:  2013-05-14       Impact factor: 6.998

3.  The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness.

Authors:  Keith A Sikora; Ndate Fall; Sherry Thornton; Alexei A Grom
Journal:  Arthritis Rheum       Date:  2012-11

4.  Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins.

Authors:  S John; R B Reeves; J X Lin; R Child; J M Leiden; C B Thompson; W J Leonard
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

5.  Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells.

Authors:  Mingce Zhang; Adrian Clausell; Tanya Robinson; Jiyi Yin; Eric Chen; Leanne Johnson; Greta Weiss; Steffanie Sabbaj; Robert M Lowe; Fred H Wagner; Paul A Goepfert; Olaf Kutsch; Randy Q Cron
Journal:  J Immunol       Date:  2012-08-08       Impact factor: 5.422

Review 6.  Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.

Authors:  A Ravelli; A A Grom; E M Behrens; R Q Cron
Journal:  Genes Immun       Date:  2012-03-15       Impact factor: 2.676

7.  Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.

Authors:  Grant S Schulert; Mingce Zhang; Ndate Fall; Ammar Husami; Diane Kissell; Andrew Hanosh; Kejian Zhang; Kristina Davis; Jeffrey M Jentzen; Lena Napolitano; Javed Siddiqui; Lauren B Smith; Paul W Harms; Alexei A Grom; Randy Q Cron
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

Review 8.  Genetic defects in cytolysis in macrophage activation syndrome.

Authors:  Mingce Zhang; Edward M Behrens; T Prescott Atkinson; Bita Shakoory; Alexei A Grom; Randy Q Cron
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

9.  Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms.

Authors:  Kejian Zhang; Jennifer Biroschak; David N Glass; Susan D Thompson; Terri Finkel; Murray H Passo; Bryce A Binstadt; Alexandra Filipovich; Alexei A Grom
Journal:  Arthritis Rheum       Date:  2008-09

10.  Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.

Authors:  Frank Cichocki; Heinrich Schlums; Hongchuan Li; Vanessa Stache; Timothy Holmes; Todd R Lenvik; Samuel C C Chiang; Jeffrey S Miller; Marie Meeths; Stephen K Anderson; Yenan T Bryceson
Journal:  J Exp Med       Date:  2014-05-19       Impact factor: 14.307

View more
  9 in total

1.  Whole exome sequencing in a juvenile idiopathic arthritis large family with SERPINA1 gene mutations.

Authors:  Cyprian Popescu
Journal:  BMC Rheumatol       Date:  2022-07-04

Review 2.  The genetics of macrophage activation syndrome.

Authors:  Grant S Schulert; Randy Q Cron
Journal:  Genes Immun       Date:  2020-04-15       Impact factor: 2.676

3.  Alternative UNC13D Promoter Encodes a Functional Munc13-4 Isoform Predominantly Expressed in Lymphocytes and Platelets.

Authors:  Donatella Galgano; Tayebeh Soheili; Matthias Voss; Lamberto Torralba-Raga; Bianca Tesi; Frank Cichocki; Isabelle Andre; Jens Rettig; Marina Cavazzana; Yenan Bryceson
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

Review 4.  The Immunology of Macrophage Activation Syndrome.

Authors:  Courtney B Crayne; Sabrin Albeituni; Kim E Nichols; Randy Q Cron
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

Review 5.  Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.

Authors:  Jessica Vandenhaute; Carine H Wouters; Patrick Matthys
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

Review 6.  The Multi-Omics Architecture of Juvenile Idiopathic Arthritis.

Authors:  Xiaoyuan Hou; Huiqi Qu; Sipeng Zhang; Xiaohui Qi; Hakon Hakonarson; Qianghua Xia; Jin Li
Journal:  Cells       Date:  2020-10-15       Impact factor: 6.600

Review 7.  COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?

Authors:  Michael J Ombrello; Grant S Schulert
Journal:  Transl Res       Date:  2021-03-05       Impact factor: 7.012

Review 8.  Recent advances in primary immunodeficiency: from molecular diagnosis to treatment.

Authors:  Giorgia Bucciol; Isabelle Meyts
Journal:  F1000Res       Date:  2020-03-19

9.  Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children.

Authors:  Anshul Vagrecha; Mingce Zhang; Suchitra Acharya; Shannon Lozinsky; Aaron Singer; Chana Levine; Maha Al-Ghafry; Carolyn Fein Levy; Randy Q Cron
Journal:  Biology (Basel)       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.